Integrated Pharma Solutions
Delivering end-to-end solutions across the healthcare value chain—from RLD sourcing and technology transfer to strategic partnerships and generic product development.
Young & Dynamic Across the Healthcare Value Chain
From sourcing Reference Listed Drugs (RLDs) to ensure benchmark quality, to executing Technology Transfers with precision and compliance, Tanimswiss Pharma transforms concepts into compliant, market-ready products. Every phase—from RLD acquisition to commercialization—is managed with scientific rigor and strategic insight. Tanimswiss Pharma doesn’t just support your pharmaceutical journey—it accelerates it.
Our integrated approach spans the entire pharmaceutical lifecycle—from early-stage technology assessment to commercial supply chain management. We combine deep regulatory knowledge with operational excellence to deliver measurable outcomes.
Whether you're developing generic medicines, medical devices, or nutraceuticals, our team provides the strategic guidance and execution capabilities needed to succeed in today's competitive market.
Integrated Services Across the Value Chain
We combine comparator sourcing, technology transfer, and strategic partnerships to move your products from concept to commercialization with confidence.
RLD Sourcing
GDP-licensed comparator sourcing with full traceability, documentation, and temperature control for clinical, bioequivalence, and regulatory programs.
- Authentic reference products across US/EU/ROW
- Chain-of-custody & cold-chain management
- Complete regulatory packet delivery
Technology Transfer
EUCTD/CTD-ready tech transfer governance that preserves knowledge, aligns quality systems, and validates processes for commercial scale-up.
- Risk-based transfer planning
- Process & analytical method validation
- Regulatory submission support
Strategic Partnerships
Out-licensing, portfolio management, and co-development frameworks that align commercial objectives and accelerate market access.
- Deal structuring & due diligence
- Contract R&D and CMO collaborations
- Lifecycle & portfolio optimization
RLD / Comparator Sourcing (US/EU/ROW)
Comprehensive comparator supply solutions with full traceability, regulatory compliance, and documentation support for bioequivalence studies and regulatory submissions.
Compliance & Traceability
- Full chain of custody documentation
- GDP (Good Distribution Practice) compliance
- Temperature-controlled shipping and storage
- Authenticity verification and anti-counterfeiting measures
- Regulatory documentation packages (CoA, CoC, import permits)
Geographic Coverage
- United States: FDA-approved reference listed drugs
- European Union: EMA-authorized reference medicinal products
- Rest of World: Regional reference products with regulatory validation
Technology Transfer (EUCTD/CTD)
Seamless technology transfer from development to commercial manufacturing, ensuring knowledge preservation, regulatory compliance, and operational excellence.
Our technology transfer services bridge the gap between R&D and commercial production, minimizing risk and ensuring continuity. We manage the complete transfer lifecycle—from initial assessment through validation and regulatory approval.
With expertise in EUCTD and CTD formats, we ensure your documentation meets international standards while maintaining process integrity and quality attributes.
Our Process
-
Discovery & Assessment
Comprehensive evaluation of source technology, facilities, and capabilities to identify transfer requirements and potential challenges.
-
Planning & Documentation
Detailed transfer plan development, including risk assessment, timeline, resource allocation, and regulatory strategy.
-
Execution & Validation
Hands-on transfer execution with process validation, analytical method transfer, and quality system alignment.
-
Regulatory Submission
Preparation and submission of regulatory variations, ensuring compliance with EUCTD/CTD requirements.
Strategic Partnerships with Contract R&D
Leverage our extensive network of contract R&D partners to accelerate development timelines and expand your therapeutic reach.
Capabilities Across Dosage Forms
- Solid Dosage Forms: Tablets, capsules, controlled-release formulations
- Liquid Formulations: Solutions, suspensions, emulsions
- Topical Products: Creams, ointments, gels, patches
- Injectable Products: Vials, pre-filled syringes, lyophilized products
- Specialty Formulations: Orally disintegrating tablets, nano-formulations
Therapeutic Areas
- Cardiovascular diseases
- Central nervous system disorders
- Oncology and hematology
- Infectious diseases
- Metabolic disorders
- Respiratory conditions
- Gastrointestinal disorders
- Dermatology
Generic Product Co-Development
Addressing market shortages and complex generics through collaborative development models that share risk and maximize value creation.
Focus Areas
- Shortage Products: Rapid development and commercialization of products facing supply constraints
- Complex Generics: High-barrier formulations requiring specialized expertise
- First-to-File Opportunities: Strategic positioning for competitive advantage
- Value-Added Generics: Enhanced formulations with improved patient outcomes
Value Creation Model
- Risk-sharing partnerships that align incentives
- Accelerated development timelines through parallel processing
- Regulatory expertise to navigate complex pathways
- Commercialization support and market access strategies
- Quality assurance and supply chain management
Ready to Accelerate Your Pharmaceutical Projects?
Partner with Tanim Pharma for end-to-end solutions that combine regulatory expertise, operational excellence, and strategic insight.